Sustainable Antimicrobial Biomaterial for Advanced Wound Care
Building Safer, Longer-Lasting Antimicrobial Materials for Healthcare
Overview
Healthcare providers and wound-care innovators face a growing need for materials that can prevent infection, support healing, and remain safe for human tissue.
Conventional silver-based antimicrobial solutions are widely used, but they can present challenges around toxicity, cost, performance consistency, and environmental impact.
Metalchemy developed a sustainable antimicrobial biomaterial platform designed to address these barriers, combining high antimicrobial performance with strong biocompatibility and a more sustainable production route.
The Commercial Challenge
In advanced wound care, infection prevention is critical. However, next-generation wound-care products must do more than kill pathogens. They must also support tissue repair, reduce safety risks, and be suitable for scalable manufacture.
Key industry challenges include:
Reducing reliance on traditional antibiotics
Improving antimicrobial performance without increasing toxicity
Creating materials that support healing, not just infection control
Lowering the environmental impact of silver-based chemistries
Building evidence to support future product development and commercial adoption
Metalchemy’s Solution
Metalchemy developed a green synthesis process for colloidal silver and integrated it into a natural, eggshell-derived biomaterial.
This created a composite material designed to:
Deliver sustained antimicrobial protection
Support tissue regeneration
Improve biocompatibility
Reduce environmental impact
Provide a platform for future wound-care and healthcare applications
Rather than relying on conventional silver chemistries, the approach demonstrates how sustainably produced colloidal silver can be engineered into high-performance biomaterials for regulated healthcare markets.
What Was Evaluated
The material was assessed across several commercially relevant performance areas:
Antimicrobial activity against fungal pathogens
Biocompatibility with human skin cells
Healing potential, including angiogenesis support
Silver release profile and stability over time
Key Results
The evaluation demonstrated strong technical and commercial potential:
Up to ~17× stronger antimicrobial activity
Compared with conventional silver materials, the composite showed significantly enhanced antimicrobial performance.
High biocompatibility
Human skin cell testing indicated strong cell viability and proliferation, supporting its potential suitability for wound-care applications.
Enhanced healing response
The material supported angiogenesis, indicating potential to assist new blood vessel formation and tissue repair.
Sustained silver release over 14 days
The controlled release profile enables longer-lasting antimicrobial protection, which is highly relevant for wound dressings and other advanced healthcare materials.
Commercial Relevance
This work demonstrates that Metalchemy’s colloidal silver platform can help healthcare and consumer health companies develop antimicrobial materials that are:
High-performing
Biocompatible
More sustainable
Suitable for advanced wound-care innovation
Capable of moving from laboratory validation toward scalable manufacture
The platform could support product development across wound dressings, antimicrobial coatings, medical materials, and selected consumer health applications.
Potential Applications
Advanced wound-care materials
Antimicrobial dressings
Medical device coatings
Antimicrobial surface coatings
Consumer health and hygiene products
Bioactive healthcare materials
Impact
Metalchemy’s sustainable antimicrobial biomaterial platform supports the development of:
Antimicrobial wound-care materials without reliance on traditional antibiotics
Safer, non-toxic antimicrobial technologies
Materials combining antimicrobial and antioxidant functionality
Sustainable alternatives to conventional wound-care chemistries
Validated biomaterials ready for further product development
Scalable manufacturing pathways for healthcare innovation
Services Delivered
Metalchemy supported the project through:
Scientific testing
Biological evaluation
Technical interpretation
Materials development
Manufacturing readiness support
Key Result
Metalchemy enables high-performance, biocompatible antimicrobial materials using sustainably produced colloidal silver — helping healthcare innovators develop safer, longer-lasting, and more sustainable solutions for advanced wound care.
